Status:
COMPLETED
Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer
Lead Sponsor:
Sun Yat-sen University
Conditions:
Inflammation
Colon Cancer
Eligibility:
All Genders
18-65 years
Brief Summary
Marginal acute inflammation would make reporting the serosal involvement of tumors controversial. We aimed to investigate the clinical significance and explore the prognostic value of MAI for stage II...
Eligibility Criteria
Inclusion
- (1) colon cancer patients with the preoperative staging of stage I-III who lacked distant metastasis; (2) patients who underwent radical resection, with postoperative pathology confirmed as pT3-4N0M0; and (3) complete follow-up information
Exclusion
- (1) patients who received neo-adjuvant therapy; (2) patients with multiple primary colorectal cancer; and (3) patients with a history of malignant tumors
Key Trial Info
Start Date :
January 30 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
1167 Patients enrolled
Trial Details
Trial ID
NCT06135558
Start Date
January 30 2016
End Date
October 30 2023
Last Update
November 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.